Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan.
Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan.
Ophthalmology. 2015 Jan;122(1):123-8. doi: 10.1016/j.ophtha.2014.07.027. Epub 2014 Sep 4.
To study the anatomic and visual outcomes of a surgical procedure in which tissue plasminogen activator and air are injected subretinally to displace massive submacular hemorrhages secondary to age-related macular degeneration.
Prospective, consecutive, interventional case series.
Thirteen consecutive patients (13 eyes) with massive submacular hemorrhages secondary to age-related macular degeneration.
The surgical procedure consisted of a 25-gauge vitrectomy and submacular injection of tissue plasminogen activator (25 μg) and 0.4 ml air with a microneedle having an outer diameter of 50 μm. The procedure was followed by having the patient remain in the prone position overnight.
Mean visual acuity change from baseline, mean central lesion thickness change from baseline, fluorescein angiography findings, and surgical complications.
Total subfoveal blood displacement was achieved in all 13 eyes (100%). Central lesion thickness decreased from a mean baseline value of 867 μm to a mean value of 379 μm at 1 month after surgery. There was visual improvement in 11 eyes, no visual improvement in 1 eye, and poorer vision in 1 eye. The mean change in Early Treatment Diabetic Retinopathy Study letter score from baseline was 19.4 letters at 1 month (P = 0.006) and 23.3 letters at 3 months (P = 0.001). There was intraoperative macular hole formation.
Submacular air injection with a microneedle facilitates displacement of clots dissolved with tissue plasminogen activator with few complications and results in earlier visual improvement.
研究一种手术方法的解剖学和视觉效果,该方法将组织纤溶酶原激活物和空气注入视网膜下,以移位因年龄相关性黄斑变性导致的大量黄斑下出血。
前瞻性、连续、干预性病例系列研究。
13 例(13 只眼)连续患者,因年龄相关性黄斑变性导致大量黄斑下出血。
手术过程包括 25G 玻璃体切除术和黄斑下注射组织纤溶酶原激活物(25μg)和 0.4ml 空气,使用外径为 50μm 的微针。手术后,让患者保持俯卧位过夜。
从基线开始的平均视力变化、平均中心病变厚度变化、荧光素血管造影结果和手术并发症。
所有 13 只眼(100%)均实现了完全黄斑下血位移位。中心病变厚度从基线的平均 867μm 下降到术后 1 个月的平均 379μm。11 只眼视力改善,1 只眼视力无改善,1 只眼视力更差。从基线到 1 个月时的早期治疗糖尿病视网膜病变研究字母评分平均变化为 19.4 个字母(P=0.006),3 个月时为 23.3 个字母(P=0.001)。术中出现黄斑裂孔形成。
用微针进行黄斑下空气注射有助于溶解组织纤溶酶原激活物的血栓移位,并发症少,视力改善更早。